Heritage's $10 million settlement in US inflated drug prices litigation gets final approval
MLex Summary: Heritage Pharmaceuticals’ $10 million settlement with US states has been granted final approval by a federal judge, resolving allegations that it conspired to artificially inflate and manipulate prices, reduce...To view the full article, register now.
Already a subscriber? Click here to view full article